What is HCP Access Targeting?
HCP access targeting is the practice of identifying and prioritizing healthcare providers (HCPs) based on their ability to prescribe and obtain coverage for a specific drug, given payer policies, formulary status, and utilization management requirements.
Rather than targeting prescribers solely by historical volume or specialty, HCP access targeting incorporates:
- Payer coverage and formulary placement
- Prior authorization and step therapy rules
- Site of care and channel access
- Patient mix and payer mix
The result is a more precise view of where access exists—and where it does not. HCP access targeting connects payer policy intelligence with prescriber behavior, helping manufacturers focus their engagement on providers who are most likely to successfully prescribe a therapy for eligible patients.
How is HCP access targeting different from traditional HCP targeting?
Traditional HCP targeting models focus on prescription volume, decile rankings, or specialty alignment. These approaches overlook a critical constraint: many HCPs cannot easily prescribe certain therapies due to payer restrictions. Common gaps in traditional targeting include:
- High-volume prescribers with limited payer coverage
- Providers practicing in highly restricted geographies
- Misalignment between sales effort and real-world access
HCP access targeting addresses these gaps by aligning commercial effort with payer reality.
How does HCP access targeting work?
HCP access targeting integrates multiple data sources to create an access-informed view of the prescriber universe. By understanding a provider’s payer mix, channel and site-of-care restrictions, and the drug’s formulary status and utilization management restrictions across national and regional payers, manufacturers can segment HCPs by likelihood of successful access, not just prescribing intent.
By leveraging coverage and claims data, manufacturers can overlay sales territory alignments with current market dynamics to better understand volume at the NPI level.
Based on the data, brand teams can continually update their HCP targeting lists, making sure that reps are engaging with the right physicians at the right time.
What are the benefits of HCP access targeting?
When HCPs understand coverage pathways and access requirements, patients are more likely to receive timely therapy. By focusing engagement on HCPs with fewer access barriers, field teams can:
- Improve call quality and relevance
- Reduce friction in the prescribing process
- Increase return on sales and marketing investment
HCP access targeting also results in better alignment between market access teams and sales, ensuring:
- Consistent prioritization
- Clear expectations around access constraints
- Faster feedback loops when payer policies change
- Optimization of pull-through and patient support programs
What are some common challenges of HCP access targeting?
HCP access targeting can be difficult to execute, as many manufacturers have limited visibility into HCP-level payer mix, and may have fragmented or out-of-date payer policy and restriction data. Without integrated data and analytics, targeting quickly becomes outdated.
MMIT helps pharma companies conduct HCP access targeting by connecting payer policy intelligence, formulary data, and prescriber insights. We help manufacturers identify HCPs with the strongest access profiles and better understand payer-driven barriers at the point of care.
